Confluence Pharmaceuticals: Funding, Investors & Team (Oct 2026)
Juncture Pharmaceuticals is creating novel remedial drugs for neurological improvement problems. The organization's ongoing center is propelling an original medication disclosure that works on friendly and correspondence weaknesses for people with Autism Spectrum Disorders and Fragile X Syndrome.
Confluence Pharmaceuticals has raised $200k across 1 funding round on record, the most recent an undisclosed round of $200k announced in Jun 2022.
That round is below the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Confluence Pharmaceuticals Company Profile and Key Stats
Latest funding round on record: Jun 2022.
Confluence Pharmaceuticals Funding Rounds
Confluence Pharmaceuticals Founders and Leadership Team
Contact details for the Confluence Pharmaceuticals team: 1 of 1 has an email address on file.
Start 14-day free trial →Confluence Pharmaceuticals Funding Compared to Other Biotechnology Startups
Confluence Pharmaceuticals' latest round of $200k is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Confluence Pharmaceuticals in Biotechnology and Indianapolis
Companies Similar to Confluence Pharmaceuticals
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Confluence Pharmaceuticals Funding FAQs
What does Confluence Pharmaceuticals do?
Juncture Pharmaceuticals is creating novel remedial drugs for neurological improvement problems. The organization's ongoing center is propelling an original medication disclosure that works on friendly and correspondence weaknesses for people with Autism Spectrum Disorders and Fragile X Syndrome.
How much funding has Confluence Pharmaceuticals raised?
Confluence Pharmaceuticals has raised $200k across 1 round on record. The most recent is an undisclosed round of $200k announced in Jun 2022.
When did Confluence Pharmaceuticals last raise funding?
Confluence Pharmaceuticals' most recent funding round on record is an undisclosed round of $200k, announced in Jun 2022.
Who founded Confluence Pharmaceuticals?
FundedIQ lists Boyd Sturdevant (Founder) at Confluence Pharmaceuticals.
Where is Confluence Pharmaceuticals headquartered?
Confluence Pharmaceuticals is based in Indianapolis, Indiana, United States.
How many employees does Confluence Pharmaceuticals have?
Confluence Pharmaceuticals is in the 1-10 employee band.
How does Confluence Pharmaceuticals' funding compare to other Biotechnology startups?
Confluence Pharmaceuticals' latest round of $200k is below the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Confluence Pharmaceuticals Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Confluence Pharmaceuticals is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.